Last updated on March 2018

Addressing Dementia Via Agitation-Centered Evaluation (ADVANCE)


Brief description of study

This is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's disease.

Clinical Study Identifier: TX198908

Find a site near you

Start Over

Meridien Research - Spring Hill

120 Medical Boulevard, #103 Spring Hill, FL USA
  Connect »